These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 20586779)

  • 21. IgG autoantibodies in patients with anti-epiligrin cicatricial pemphigoid recognize the G domain of the laminin 5 alpha-subunit.
    Lazarova Z; Yee C; Lazar J; Yancey KB
    Clin Immunol; 2001 Oct; 101(1):100-5. PubMed ID: 11580232
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bullous Pemphigoid in Infancy Showing Epitope-spreading Phenomenon: Recovery with Topical Therapy.
    Matsuda H; Oiso N; Ishii N; Sato M; Tatebayashi M; Hashimoto T; Kawada A
    Acta Derm Venereol; 2015 May; 95(5):610-1. PubMed ID: 25424244
    [No Abstract]   [Full Text] [Related]  

  • 23. Bullous pemphigoid--a report of 86 cases from Taiwan.
    Chang YT; Liu HN; Wong CK
    Clin Exp Dermatol; 1996 Jan; 21(1):20-2. PubMed ID: 8689763
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential role of interleukin-17 in the pathogenesis of bullous pemphigoid.
    Toosi S; Bystryn JC
    Med Hypotheses; 2010 Apr; 74(4):727-8. PubMed ID: 19945799
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bullous pemphigoid in a patient with Parkinson's disease.
    Forschner A; Ulmer A; Rassner G; Fierlbeck G
    Eur J Dermatol; 2002; 12(6):615. PubMed ID: 12506886
    [No Abstract]   [Full Text] [Related]  

  • 26. Bullous pemphigoid initially localized around a urostomy.
    Torchia D; Caproni M; Ketabchi S; Antiga E; Fabbri P
    Int J Dermatol; 2006 Nov; 45(11):1387-9. PubMed ID: 17076741
    [No Abstract]   [Full Text] [Related]  

  • 27. Chronic bullous disease of childhood with IgG reactivity to p200 antigen.
    Patsatsi A; Meltzanidou P; Katafigiotis S; Sotiriadis D; Schmidt E; Lambropoulos A
    Int J Dermatol; 2017 Jul; 56(7):773-775. PubMed ID: 28436028
    [No Abstract]   [Full Text] [Related]  

  • 28. Anti-epiligrin cicatricial pemphigoid: a case associated with gastric carcinoma and features resembling epidermolysis bullosa acquisita.
    Fujimoto W; Ishida-Yamamoto A; Hsu R; Nagao Y; Iizuka H; Yancey KB; Arata J
    Br J Dermatol; 1998 Oct; 139(4):682-7. PubMed ID: 10025973
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in the autoimmune blistering response: a clinical and immunopathological shift from pemphigus foliaceus to bullous pemphigoid.
    Maeda JY; Moura AK; Maruta CW; Santi CG; Prisayanh PS; Aoki V
    Clin Exp Dermatol; 2006 Sep; 31(5):653-5. PubMed ID: 16901304
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of bullous pemphigoid with enteric-coated mycophenolate sodium.
    Tursen U; Guney A; Kaya T; Ikizoglu G
    J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):542-4. PubMed ID: 17373988
    [No Abstract]   [Full Text] [Related]  

  • 31. A case of antilaminin 332 mucous membrane pemphigoid showing a blister on the bulbar conjunctiva and a unique epitope on the alpha3 subunit.
    Hashimoto T; Dainichi T; Ohyama B; Hamada T; Ishii N; Sato N; Tanigawa O; Nakayama J; Amano S; Nishiyama T; Karashima T; Nakama T; Yasumoto S
    Br J Dermatol; 2010 Apr; 162(4):898-9. PubMed ID: 20199543
    [No Abstract]   [Full Text] [Related]  

  • 32. [Immunologic phenomena in the skin of patients with pemphigoid in relation to the pathologic process].
    Torzecka JD; Lutowiecka-Wranicz A; Sysa-Jedrzejowska A; Waszczykowska E; Dziankowska-Bartkowiak B
    Przegl Dermatol; 1988; 75(4):266-71. PubMed ID: 3070636
    [No Abstract]   [Full Text] [Related]  

  • 33. Transition from pemphigus foliaceus to bullous pemphigoid: intermolecular B-cell epitope spreading without IgG subclass shifting.
    Recke A; Rose C; Schmidt E; Bröcker EB; Zillikens D; Sitaru C
    J Am Acad Dermatol; 2009 Aug; 61(2):333-6. PubMed ID: 19615544
    [TBL] [Abstract][Full Text] [Related]  

  • 34. From anti-p200 pemphigoid to anti-laminin gamma1 pemphigoid.
    Dainichi T; Koga H; Tsuji T; Ishii N; Ohyama B; Ueda A; Natsuaki Y; Karashima T; Nakama T; Yasumoto S; Zillikens D; Hashimoto T
    J Dermatol; 2010 Mar; 37(3):231-8. PubMed ID: 20507386
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cicatricial pemphigoid with autoantibodies against the laminin 5 gamma 2 subunit.
    Dainichi T; Takeshita H; Moroi Y; Urabe K; Yoshida M; Hisamatsu Y; Komai A; Duan H; Koga T; Hashimoto T; Furue M
    Eur J Dermatol; 2005; 15(3):189-93. PubMed ID: 15908306
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subepidermal blistering disease with autoantibodies to both the p200 autoantigen and the alpha3 chain of laminin 5.
    Shimanovich I; Petersen EE; Weyers W; Sitaru C; Zillikens D
    J Am Acad Dermatol; 2005 May; 52(5 Suppl 1):S90-2. PubMed ID: 15858518
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical manifestations in 100 Japanese bullous pemphigoid cases in relation to autoantigen profiles.
    Tanaka M; Hashimoto T; Dykes PJ; Nishikawa T
    Clin Exp Dermatol; 1996 Jan; 21(1):23-7. PubMed ID: 8689764
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A case of bullous pemphigoid in a patient on hemodialysis.
    Kamada N; Ino N; Hatamochi A; Shinkai H
    J Dermatol; 1998 Apr; 25(4):246-9. PubMed ID: 9609983
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of anti-laminin γ1 pemphigoid with mycophenolate mofetil.
    Gawaz A; Metzler G; Hertl M; Hashimoto T; Schaller M
    J Dtsch Dermatol Ges; 2015 Jul; 13(7):696-7. PubMed ID: 26058852
    [No Abstract]   [Full Text] [Related]  

  • 40. A vesicular variant of bullous pemphigoid with autoantibodies against unidentified 205- and 150-kDa proteins at the basement membrane zone.
    Satoh S; Seishima M; Izumi T; Ito A; Kamiya H; Kitajima Y
    Br J Dermatol; 1997 Nov; 137(5):768-73. PubMed ID: 9415239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.